ICU
LMF Acquisition Opportunities Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
SeaStar Medical Holding Prices $9 Million Registered Direct Stock Offering
Are pharma penny stocks risky in this type of market?
Mods deleting every $ICU post. This is an overstep. Disgusting.
Why is r/pennystocks removing valid posts re $ICU,
$CLNN. Money maker but not widely discussed
What happend at 14:30 each day to cause these drops? $ICU
I will tell you everything I am invested in, you rate my portfolio. 1 to 5. 5 being awesome....
$ICU - UNDERSTAND THE INVESTMENT OPPORTUNITY THAT IS SEASTAR MEDICAL IN 30 MINUTES (INTERVIEW WITH CEO AND HEAD OF MEDICAL)
$ICU sell on fda approval or in for the long hold?
$ICU released an update on the 11th
$ICU - SeaStar Medical Names David Green as Finance Chief, Mentions Commercial Launch of SCD-PED LATER THIS QUARTER (IMPLYING FDA APPROVAL)
Title: "Exciting News: $LMFA's Investment in $ICU - Seastar Medical and the Potential Stock Surge"
ICU Seastar medical fda approval soon
$ICU - SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications
$ICU - Oversold, Reversal Confirmed, FDA Approval Imminent - Will SeaStar be the Next 100% Pennystock Gainer in January?
$BSFC in early just like. RNAZ,ICU, and INBS
Anybody still holding ICU? what’s your play?
Discover the next Nokia: 4 penny stocks with big potential
Seastar Medical ($ICU)
ICU SeaStar Medical SQUEEZING Monday Oct 30th 2023
ICU - SeaStar Medical, shirt squeeze incoming
BULLISH: Seastar Medical Holding Corp ($ICU) Has Serious Potential
BULLISH: Seastar Medical Holding Corp ($ICU) Has Serious Potential
ICU SeaStar Medical, 3rd FDA approval breaking just now
Anybody getting in on the short squeeze potential around SeaStar Medical (ICU)?
ICU 1-week play: Get in now, get out before November
My stock watchlist for this week!
(Bullish on ICU) Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
SeaStar Medical Holdings (ICU) insane potential.
SeaStar Medical Holdings (ICU) insane potential.
$MGUY - Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)
ICU multi day runner and setup for squeeze to 2 plus
Stocks to have an eye on for Monday
$ICU on an amazing run, FDA breakthrough device designation
Two penny stocks that are "strong buys" and could rise in value to $10 or more.
On this day of liberation, a DD thread on an actually cool product, that can make a huge difference. (Plus pre-hype AI)
$ICU 2.6 mill FLOAT deSPAC IMO we get back to $4's
ICU bull trap today but possible good squeeze
Got caught in ICU's bull trap and left at a 300$ loss
Mentions
Same for me, invested in 1) Nigerian scam TIOG, 2) penny stock ICU, and 3) #1 SeekingAlpha stock ASRT… sold winners too early to reinvest in the losers. Took a different approach per 2025Q3 NVDA results (first day ending was shite too), but things are going better.
No no, it’s all the ICU and DHS hires your lovely country hired. Gotta use your tax money for something am I right murica?
I misworded and meant rehab wasn't too expensive for me, I edited my comment. Yea I spent 4 days in ICU for the severe dehydration and they took liver tests since I was jaundice. Straight from there to a rehab, maybe the social worker sold it to me, but she said insurance may not cover if they hear I went home for a night. 2nd day a seizure and back to hospital. Back to rehab after like a day and a half. Finish 30 day rehab, got told the test showed cirrhosis. After 6 months sober it ended up the cirrhosis was misdiagnosed due to liver being so swollen and I showed no signs of damage to myself from drinking. So glad it happened the way it did. Scared the shit outta me to finally get sober.
$ICU from january 5th is going viral
Whether silver goes up or down, every single oz will be hoarded until spent by diabetic boomers on desperate ICU stays. Not one greedy grandchild child will see a single penny if it means an extra week here on earth.*
I just finished anesthesia for a craniotomy for brain lesion on a 72 year old with known renal cell cancer. So many comorbidities she’s between a rock and a hard place without the cancer. Every service line in the hospital tried to talk the family out of craniotomy and ICU, yet they insisted on it all. That’s the insanity I see every day at my hospital. The curse of “meemaw would want this”. Nobody in their right mind would want what we are doing to these people.
We shall see …. about two of those! ;) $IVP and $SONM come to mind. How about $ICU?
$ICU just made a thesis post [https://www.reddit.com/r/pennystocks/comments/1ppy81n/seastar\_medical\_300bagger\_thesis\_from\_vic/](https://www.reddit.com/r/pennystocks/comments/1ppy81n/seastar_medical_300bagger_thesis_from_vic/)
Here's an interesting article on the Medline ETO plant and high cancer rates in the area. Specifically breast cancer in their own neighborhood where their community lives. www.cbsnews.com/amp/chicago/news/cdc-study-carcinogenic-gas-near-north-suburban-chicago-facilities/ I remember that time when they got smacked in an antitrust lawsuit. https://www.falseclaimsact.com/medline-settles-kickback-case-for-85m/ The time that thru got caught selling fake implantable surgical mesh. Counterfit implants. https://www.theclarkfirmtexas.com/medline-faces-counterfeit-mesh-lawsuits/ The time they simply forgot to sterilize the custom surgical packs. Ooops! https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=213288 The time they sold unsterile water used in kits for the ICU https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/alert-medline-industries-lp-removes-certain-sterile-medline-convenience-kits?hl=en-US#:~:text=These%20kits%2C%20meant%20to%20be,%2C%20fevers%2C%20sepsis%20and%20death. Faulty syringes https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/convenience-kit-component-recall-medline-industries-lp-removes-convenience-kit-syringes-manufactured?hl=en-US#:~:text=Notify%20any%20company%20or%20individual,or%20have%20other%20quality%20issues. Too many OSHA, labor relations, hazard waste violations to count https://violationtracker.goodjobsfirst.org/parent/medline-industries?hl=en-US#:~:text=Medline%20Industries%20Inc.-,False%20Claims%20Act%20and%20related A 2014 federal private lawsuit settlement of $1.6 million, often related to issues like employee time rounding and miscalculating overtime pay with bonuses.
https://www.impactguru.com/fundraiser/help-sambhu-nath-bhowal?utm_source=smc&utm_term=1&utm_medium=2001409 Thank you to everyone who is taking the time to read or share this. I will post medical updates regularly. Your help is directly going towards hospital bills and ICU care.
Thank you to everyone who is taking the time to read or share this. I will post medical updates regularly. Your help is directly going towards hospital bills and ICU care.
My dumb ass has a $26 average and of all the dog shit stocks Im bag holding (OM, ICU the worst besides sbet) sbet is the one I’m going to tax harvest. I’ll never buy another crypto treasury or bio pharma stock again. Said this after atyr, but I mean it this time.
So Google just made it out of the ICU and is now in the step down unit recovering well
Fake news, he's not dead, just in ICU https://www.youtube.com/watch?v=dQw4w9WgXcQ
I’ll check it out thanks for the heads up, in the mean time checkout ICU. They are presenting at a private investment conference today. They have some quality products in the FDA pipeline and one that’s already been approved, they got until the 18th to regain compliance, also no debt. Could be an easy 2x this week or next 🤝
Check out ICU next my guy and run it through your fancy scanner 🤝
Please, before jumping into ICU because they got "FDA approval", read the whole sentence; "FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry" Approval for REDUCTION IN MANDATORY ENROLLMENT. Meaning the FDA said alright, it's okey if you only take 50 patients instead of 300. *...from the originally-required 300 patients to only 50 patients.*
No, $ICU. It's .32 cents, also called seastar medical.
Is it this one? DENVER, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) has approved a reduction in the mandatory enrollment size of the [SAVE Surveillance Registry](https://www.globenewswire.com/Tracker?data=tcx20eicLXmx9mLmPlsdnvqu3bpt144bCCfRLpIfuls_50qMAO3s20uRDTvrfcqo4Mk3FW7FUgts03jVL0ivtQ6hFgT7pVo_Wgo_Ar5zRr-bW4QzSM5UWXllaEn_T_RPuczFX3tPqcRuHov4bjY1lr8j1DZlK0RpI6uo9eBlvVg=) from the originally-required 300 patients to only 50 patients. This new 50-patient registry size will satisfy the post-approval surveillance requirement by the FDA as outlined in the original Humanitarian Device Exemption (HDE) approval and indicates that FDA believes that continued device safety can be successfully shown with fewer patients than originally required. The SAVE Surveillance Registry is a Post-Approval Study (PAS) that is designed to confirm the safety of the QUELIMMUNE therapy, which was approved in 2024 as a treatment for children with acute kidney injury (AKI) and sepsis or a septic condition. To date, data from 32 pediatric patients have been entered into the SAVE Surveillance Registry. “We are grateful for this decision by the FDA and believe, once the registry is complete, it will enable us to expand the potential organ-sparing and life-saving benefits of our QUELIMMUNE therapy to more pediatric patients with AKI,” stated Eric Schlorff, CEO of SeaStar Medical. “These kids typically have about a 50% survival rate and our data from the first 21 patients in the SAVE Surveillance Registry showed zero device-related adverse events and a clear improvement to 70% survival at 90 days. This decision is a win-win for patients, their families, health care providers, and the overall health care system. We thank the FDA for their rapid evaluation of the required enrollment size of the mandatory surveillance requirements for the registry.”
DENVER, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) has approved a reduction in the mandatory enrollment size of the [SAVE Surveillance Registry](https://www.globenewswire.com/Tracker?data=tcx20eicLXmx9mLmPlsdnvqu3bpt144bCCfRLpIfuls_50qMAO3s20uRDTvrfcqo4Mk3FW7FUgts03jVL0ivtQ6hFgT7pVo_Wgo_Ar5zRr-bW4QzSM5UWXllaEn_T_RPuczFX3tPqcRuHov4bjY1lr8j1DZlK0RpI6uo9eBlvVg=) from the originally-required 300 patients to only 50 patients. This new 50-patient registry size will satisfy the post-approval surveillance requirement by the FDA as outlined in the original Humanitarian Device Exemption (HDE) approval and indicates that FDA believes that continued device safety can be successfully shown with fewer patients than originally required. The SAVE Surveillance Registry is a Post-Approval Study (PAS) that is designed to confirm the safety of the QUELIMMUNE therapy, which was approved in 2024 as a treatment for children with acute kidney injury (AKI) and sepsis or a septic condition. To date, data from 32 pediatric patients have been entered into the SAVE Surveillance Registry. “We are grateful for this decision by the FDA and believe, once the registry is complete, it will enable us to expand the potential organ-sparing and life-saving benefits of our QUELIMMUNE therapy to more pediatric patients with AKI,” stated Eric Schlorff, CEO of SeaStar Medical. “These kids typically have about a 50% survival rate and our data from the first 21 patients in the SAVE Surveillance Registry showed zero device-related adverse events and a clear improvement to 70% survival at 90 days. This decision is a win-win for patients, their families, health care providers, and the overall health care system. We thank the FDA for their rapid evaluation of the required enrollment size of the mandatory surveillance requirements for the registry.”
DENVER, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) has approved a reduction in the mandatory enrollment size of the [SAVE Surveillance Registry](https://www.globenewswire.com/Tracker?data=tcx20eicLXmx9mLmPlsdnvqu3bpt144bCCfRLpIfuls_50qMAO3s20uRDTvrfcqo4Mk3FW7FUgts03jVL0ivtQ6hFgT7pVo_Wgo_Ar5zRr-bW4QzSM5UWXllaEn_T_RPuczFX3tPqcRuHov4bjY1lr8j1DZlK0RpI6uo9eBlvVg=) from the originally-required 300 patients to only 50 patients. This new 50-patient registry size will satisfy the post-approval surveillance requirement by the FDA as outlined in the original Humanitarian Device Exemption (HDE) approval and indicates that FDA believes that continued device safety can be successfully shown with fewer patients than originally required. The SAVE Surveillance Registry is a Post-Approval Study (PAS) that is designed to confirm the safety of the QUELIMMUNE therapy, which was approved in 2024 as a treatment for children with acute kidney injury (AKI) and sepsis or a septic condition. To date, data from 32 pediatric patients have been entered into the SAVE Surveillance Registry. “We are grateful for this decision by the FDA and believe, once the registry is complete, it will enable us to expand the potential organ-sparing and life-saving benefits of our QUELIMMUNE therapy to more pediatric patients with AKI,” stated Eric Schlorff, CEO of SeaStar Medical. “These kids typically have about a 50% survival rate and our data from the first 21 patients in the SAVE Surveillance Registry showed zero device-related adverse events and a clear improvement to 70% survival at 90 days. This decision is a win-win for patients, their families, health care providers, and the overall health care system. We thank the FDA for their rapid evaluation of the required enrollment size of the mandatory surveillance requirements for the registry.”
ICU big news get in now before it explodes
ICU bottoming out...will rebound big time
Hard agree. I ended up managing an estate for a cousin who chose this route *along with his spouse who was suffering from Lyme disease.*. His effort worked, hers did not. So I basically had to unfuck his will to get everything allowed under the law back to his surviving spouse. She spent some time in ICU with jaundice from blowing up her liver and eventually moved in with her elderly father. I can only imagine the regret.
If the stock market keeps going like this next week, I’m seriously hoping the bear takes a permanent vacation... straight to the ICU
[VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge](https://finance.yahoo.com/news/vsee-health-pioneers-telehealth-expansion-132100111.html) might be something just posted this news 1/2 hour ago.
That’s a terrible idea. Do you know how much major care actually costs? Unless that child is coming from a rich family there is no way they would have that money. A few years ago my mother was in the ICU for weeks and that bill came out to be nearly 100k without insurance. One major injury could destroy you financially.
It’s because if you get a bill for $1M after a long stay in the ICU with round-the-clock care, you still only owe $16k.
I got hit hard by the early covid19 wave. In March-April 2020 I spent 38 days in Hospital (16 of those days in ICU on a Ventilator). Last full write up (including Lung X-rays) is [here](https://www.reddit.com/r/AskReddit/comments/oi4b31/_/h4t9dek/?context=1) Total bill was somewhere around $880k. I do have a screenshot (below) when the Bill was around $830k (not the final total). Thankfully, because it was covid19, I didn't have to pay any of that,.. but you're totally correct, unexpected things can be very expensive. https://imgur.com/qy4TSbJ.jpg
I’m very hopeful for ICU and IBRX
TNMG is my gamble play. really just bullish on it because I think Asia is a up and coming market and I think this company actually is making moves towards growth. Maybe some big fish will pump it randomly. DFLI will see some movement this month but I will sell the second it reaches a good price point. (Im in @ 1.08) BYND is just my dumb bag. holding it with a prayer that we will see some miracle of a run up in the next 2 months. Will sell it before Christmas unless a miracle happens. NRXP, IXHL, ICU, MBOT, IBRX are my pharma stocks. Long term gambles that I hope pay off. ATCH I am selling this month once the price hits .45. I got in at .23 and made very good profits but just tired of seeing it on my books. ill scalp it again in the future.
Normally biotech go completely dormant between trial announcements and reverse splits, I remember one of my first pennies was ICU back in 2020 I just knew I’d get rich off that.. sold after 6 months of nothing lol
Medical person who worked the ICU here… COVID was (hopefully) a once in a lifetime phenomenon. It was made worse by the government’s dereliction of disbanding the pandemic preparedness plan instituted prior. Even with that, we would have been in dire straits. People didn’t just die from the disease but from complications from it and inability to get appropriate care early on. Yes it was largely old patients, those who are poorer, and those with chronic conditions. However, had the country continued business as usual, much much more would have died that weren’t in those demographics. It’s extremely myopic to believe continuing/keeping everything open at the cost of American lives was the prudent move, especially financially. A substantial amount of the work force could have been even more impacted had we remained open.
A friend of mine who is a therapist used to do that in ICU and the nurses would be rushing to clean the patients.
I’m probably regarded but DFLI, CTM, BYND, CGTX, ICU, AIRE, ENLV, and ATCH. Just adding like 5-10 shares each at a time
ATCH... revenue up 51%...check out after hours.. wow YDKG...chinese stock....too cheap. May squeeze GPUS...still holding from last runup...looking good this week. WCT...up 11% after hours. Keep your eye on this. Holding on to BYND, ICU, and IXHL.
Lets all focus on BYND and AIRE 1st. With BYND shares scarce and borrowing interest rates high...we can pressure more upward movement on the shorts. Next ones (maybe next week) to pump are IXHL, or YYAI, or ORIS, or ICU. Those above actually are still cheap and have NOT run up.
Lets all focus on BYND and AIRE 1st. With BYND shares scarce and borrowing interest rates high...we can pressure more upward movement on the shorts. Next ones (maybe next week) to pump are IXHL, or YYAI, or ORIS, or ICU. Those above actually are still cheap and have NOT run up.
YYAI ORIS IXHL ICU These four have not runup yet. Due for a squeeze.
Fcuk that...focus on BYND and AIRE 1st. Next ones to pump are IXHL, YYAI, ORIS, or ICU. Those above actually are still cheap and haven't NOT run up.
BYND to $5 AIRE...over $1 Others still on ground floor, that have NOT runup: IXHL ICU ORIS
I called AIRE...check my comment history ...should hit $1 Other ones to squeeze is IXHL ORIS ICU...LT hold
BYND AIRE ICU IXHL ORIS YYAI I hope if we all hold, and dip in, the squeeze can continue....
ICU is not crap. Long term this one is a gold mine
The crap stocks I'm still holding: ICU, EZGO, BLMZ, BNKK 
Lost money on all. Accept for ICU😒 YYAI BYND ORIS IXHL ICU...this didn't do too bad IXHL GPUS Ugh...holding...Hopefully it gets better. Concerns about bad bank loans and Chyna!! dragging down market.
All my pennystocks are getting their ass kicked today 😒 YYAI BYND ORIS IXHL ICU...this didn't do too bad IXHL GPUS Ugh...holding...Hopefully it gets better. Concerns about bad bank loans and Chyna!! dragging down market.
Had to ask the AI gods about ICU, fuck it, in 1k shares SeaStar Medical (ICU) has moderate to high short squeeze potential due to its high short interest (18.51% of float) and small float size, which could amplify price moves. The days-to-cover ratio of 3.41 suggests a squeeze could unfold over a few days if triggered, but the lack of a recent strong bullish catalyst and the stock’s downward trend reduce the immediate likelihood. However, a sudden positive development or coordinated buying (e.g., by retail investors) could ignite a squeeze, especially given the stock’s low price and volatility. 
what's up with $ICU today 
BYND...Lotta chatter on BYND, eyeing this to add tomorrow. Lots of short interest. ICU... Turnaround company. Kidney therapeutics up 11%. Still cheap. Search my comments history, I've mentioned this several times. AIRE...ai software platform to aid in mortgage loans, title processing. Fed is cutting rates, this will spur home sales. Up 5%. Search my comments history, I've mentioned this several times. ORIS...seems to be gaining momentum. Good to squeeze, still cheap. Search my comments history, I've mentioned this several times. IXHL... potential to squeeze. YYAI..yeah I know...Sue me...itsa Penny stocks not the mag 7...still holding...it will squeeze. SENS.. own a little. RS this coming friday..it may pump before tomorrow..if not, no biggie, just dipped my toes. GPUS...sold most for profit, but holding like 200 shares long term
Check out ICU...they do kidney therapeutics...new manganement. Same with ORIS,starting to pump. Search my comment history and I've mentioned this several times. Get in...not too late. Im also in AIRE, IXHL...check that out . YYAI...Just holding it should go up.
Made some good money yesterday on DFLI and MVST. MVST is a long term play. Selling that when it buys me a car. DFLI is a 2-6month play for me. Still holding BURU and ATCH because I’m still 100%+ gains on both and have sold the majority of both positions at their peak so letting the rest ride to see if we get some late action. MBOT, IXHL, ICU, IBRX, are ones that I have small positions in just to fuck around and hope they blow up. Still looking for something spicy to end this week strong.
Heh, yeah, I'm invested in ICU and they keep having to dilute. Made me wary of any stocks with multiple RS. I invested in ICU after their RS and approval as a humanitarian device for children. Figured they would start making revenue and dilution wouldn't be much of a risk during the adult trial. Of course, it is time consuming for hospitals to approve a humanitarian device, and the adult trial is taking longer than expected. This has resulted in much more dilution than I first expected. The issue with APVO is how long after approval will they start making a profit? They will need to get medical sites and insurance to use their drug, and that takes time. Pharmaceuticals are just very slow, even with excellent news.
I am long holding ICU. They are a medical device company that has a device that stops cytokine storms, a medical emergency that doesn't have many good options. Their device is already approved for use in children as a Humanitarian Device Designation, while the adult trial for full FDA approval is underway. The device greatly improved survival rates, and more critically (for insurance companies), almost all patients who used the device did not develop the need for dialysis after recovery. It is being considered for multiple other conditions under FDA breakthrough device designation, which is meant to speed up potential approval, with a large pipeline of conditions it could help with. Other nations have also shown an interest in the device, greatly expanding the market outside the US. The device reached the halfway point of the trial this August. And while many people were expecting an early halt, the FDA ruled for the trial to continue. It will be another year for the trial to wrap up at current patient recruitment rates. The company is debt free and has enough cash to get through the first quarter of 2026. They are making sales from children's hospitals that have signed up for the device, but expansion to more hospitals has been slower than expected. Expect more dillution in 2026 to fund finishing the adult trial.
I still have it, I sold off gradually to.recover my cost basis and then some, I have like 250 shares left. I still have GPUS, ICU, SENS, and IXHL.
I'm still in GPUS SENS...got into this today. They beat earnings. As another poster has mentioned, it will squeeze up b4 their RS. BNAI... still going strong. Like SENS, it has a delisting ( not an RS) which should mean inflows to get this over $1. ICU....kidney therapeutic IXHL... something about another company acquiring it. Speculation.
Still in: GPUS ...still has momentum BNAI...squeeze to over .85 IXHL...hopium SENS.. pushing up CTM ...govt contracts / long term and ICU...long term; kidney therapeutic so sue me.
GPUS IXHL ICU We cant get these to close to $1 I posted yesterday that it was too late for me to get into FEMY because it had already gone up too much....another poster told me I was wrong and it could still squeeze up....you were RIGHT, and I WAS WRONG. my apologies .
ICU is a frustrating stock and a long term play. Not good for a scalp. But great future in 2-3 years.
BNAI... room to run for those who still holding...it can touch $1...delisting notice cause push to $1. ICU...turnaround story. Kidney therapeutic IXHL...possible acquisition by ResMed CTM... govt contracts
You're better off in BNAI or ICU. ICU dipped today so u can get in cheaper. BNAI has a delisting notice so people will still come in to send this to over $1 like we did with DVLT.
Hopefully we can get bnai over $1 like we did with DVLT. Im still in ICU, LXHL.
Thabk u sir..hopefully we can get bnai over $1 like we did with DVLT. Im still in ICU, LXHL. Sad about GPUS . 😞
Tha k you all! BNAI is doing really well. I hope ICU and IXHL can carry on. GPUS im break even...I hope it has more steam.
GPUS... wish it had more legs 😞 BNAI...going gangbusters AfterHours! IXHL... did well today almost 7%. ICU... also did quite well...turnaround story...kidney treatment. Missed out on Dfli. Sad
ICU mentioned on Barron's Roundtable as a turnaround story, new management, another user posted the video. Bnai...ai advertising...too cheap, squeeze potential. LXHL...possible ResMed acquisition
Does GPUS still have legs? Keep with BNAI, ICU, and IXHL. Missed out on DFLI 😞
Buru, ICU, And BNAI doing quite well.
For those who want to make profit, check out RVSN and ICU
Yeah another poster. AOCA**HOLE, mentioned BNAI for some weeks and IXHL and ICU these past days and he or she kept getting dowvoted also?? But they did well? I think these tickets are too cheap.
For me personally, I think I missed too much of the runup. Just my opinion. I think GPUS can hit .80. I feel it still has legs. BNAI, ICU, and IXHL still cheap imo. More room to power up.
To the the other participants who mentioned BNAI, GPUS, LXHL...thank you. I missed out on DVLT unfortunately. I will be adding ICU and CTM.
Locked in on: GPUS BNAI IXHL and ICU
Dude, up 64% already these past 5 days. BNAI IXHL ICU These three are still on the ground floor. Check those out. GPUS imo still has legs.
ICU... did well today. New management, turnaround GPUS...it can squeeze to .70s BNAI...did well today...ive mentioned this several times in here. Too cheap. AI advertising IXHL...possible acquisition from ResMed.
ICU...up over 6%... kidney treatment trial
ICU dropped for a good reason, stay away
Folks should also looking at ICU...medical device company....turnaround mode BNAI...AI advertising GPUS...good squeeze today
Well considering I was treating patients in the COVID ICU, I wore masks, practiced hand hygiene, and was inclined to get the vaccine and the first booster. All that managed to do was help me go 3 years without getting COVID despite direct exposure. Ironically I sat next to a coughing unvaccinated infected person on a plane after my first booster expired before finally getting it. Then again I believe in evidence-based medicine. Some may call that being in favor of facts over feelings but I try to be patient with the less informed.
I literally just linked a study from the Annals of Internal Medicine saying that outcomes get worse for these hospitals after acquisition. Keep straining to confirm your bias, champ. > After private equity acquisition, hospitals on average reduced salaries and staffing relative to nonacquired hospitals, notably in the EDs and ICUs, which are higher-acuity and staffing-sensitive areas. This decreased capacity to deliver care may explain the increased patient transfers to other hospitals, shortened ICU lengths of stay, and increased ED mortality.
IXHL, MYO, ADAP, IPST, ICU, ORIS, AIIO to name a few